Your browser doesn't support javascript.
loading
Role of Systemic Inflammatory Reaction in Female Genital Organ Malignancies - State of the Art.
Mleko, Michal; Pitynski, Kazimierz; Pluta, Elzbieta; Czerw, Aleksandra; Sygit, Katarzyna; Karakiewicz, Beata; Banas, Tomasz.
Afiliación
  • Mleko M; Department of Gynecology and Oncology, Jagiellonian University Medical College, Krakow, Poland.
  • Pitynski K; Department of Gynecology and Oncology, Jagiellonian University Medical College, Krakow, Poland.
  • Pluta E; Department of Radiotherapy, Maria Sklodowska-Curie Institute - Oncology Centre, Krakow, Poland.
  • Czerw A; Department of Health Economics and Medical Law, Medical University of Warsaw, Warsaw, Poland.
  • Sygit K; Department of Economic and System Analyses, National Institute of Public Health - NIH, Warsaw, Poland.
  • Karakiewicz B; Calisia University, Kalisz, Poland.
  • Banas T; Subdepartment of Social Medicine and Public Health, Department of Social Medicine, Pomeranian Medical University, Szczecin, Poland.
Cancer Manag Res ; 13: 5491-5508, 2021.
Article en En | MEDLINE | ID: mdl-34276227
ABSTRACT
Systemic inflammatory reaction (SIR) is an unfavorable prognostic factor in many malignancies and has a role in all stages of the neoplastic process initiation, promotion, and disease progression. Analysis of SIR can be performed by assessing indicators (eg, lymphocyte-to-neutrophil, platelet-to-lymphocyte, and monocyte-to-neutrophil ratios) and products of neutrophils and lymphocytes (ie, the systemic immune-inflammation index), or by examining the relationship between levels of C-reactive protein and albumin (based on the Glasgow Prognostic Score, modified Glasgow Prognostic Score, and C-reactive protein-to-albumin ratio). Risk stratification is essential in the clinical management of cancer; hence, the evaluation of these factors has potential applications in the clinical management of patients with cancer and in the development of new therapeutic targets. This review summarizes the current knowledge on SIR indicators and presents their clinical utility in malignancies of the female genital organs.
Palabras clave

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Manag Res Año: 2021 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Manag Res Año: 2021 Tipo del documento: Article País de afiliación: Polonia